GLENMARK

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Glenmark Pharmaceuticals Limited

Glenmark Pharmaceuticals Limited (GLENMARK) operates in the Healthcare sector as a Drug Manufacturer - Specialty & Generic. The company develops, manufactures, and sells generics, ...

हिन्दी में

Glenmark Pharmaceuticals Limited (GLENMARK) हेल्थकेयर क्षेत्र में एक विशिष्ट और जेनेरिक दवा निर्माता के रूप में कार्यरत है। कंपनी भारत, उत्तरी अमेरिका, यूरोप और अंतरराष्ट्रीय स्तर ...

₹2,192.2-3.95%1D
Previous trading day close · Data updates after market close
1W: -6.0%
1M: -11.4%
6M: +1.3%
1Y: +11.2%
66/100
AverageResearch Score
Market Cap
₹60.7K Cr
Large Cap
P/E Ratio
34.42
Fair
P/B Ratio
5.89
Premium
ROE
12.5%
Decent
ROCE
16.2%
Good
Debt / Equity
0.06
Low debt
Div. Yield
0.1%
EV/EBITDA
13.21
Attractive
52W Low: ₹1,792.6Current: ₹2,192.252W High: ₹2,537.6
At 54% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
72/100
Growth
Revenue, EPS, profit growth
86/100
Valuation
PE, PB, EV/EBITDA vs sector
39/100
Risk
Debt levels, volatility, coverage
66/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
34.42(Fair)
Forward P/E
22.58(Premium)
P/B Ratio
5.89(Premium)
P/S Ratio
3.49(Good)
EV/EBITDA
13.21(Attractive)
Dividend Yield
0.1%
5Y CAGR
27.2%(High growth)
Revenue Growth
23.1%(High)
Profitability
ROE
12.5%(Average)
ROCE
16.2%(Good)
ROA
6.9%(Average)
Net Margin
10.1%(Decent)
EBITDA Margin
16.6%
Financial Health
Debt to Equity
0.06(Low debt)
Current Ratio
1.56(Healthy)
Quick Ratio
1.05(Good)
Interest Coverage
10.51x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
32(Neutral)
RSI Exp (14)
26(Oversold)
MACD
-31.842(Bearish)
MACD Signal
-6.677
BB Position
-14%(Lower band)
BB Width
12.41%(Normal)
ADX (14)
35.8(Strong trend)
Williams %R
-96.3(Oversold)
MFI (14)
33(Neutral)
CCI (20)
-206(Oversold)
Stoch %K
4(Oversold)
ATR (14)
69.13(Avg True Range)
OBV (M)
33.6(Positive)
1W OBV Chg
-6.4%(Decreasing)
Rel Volume
1.48x(Normal)
Volatility
30.3%(Moderate)
Max DD 1Y
-29.7%(Moderate)
Alpha (CAPM)
6.65%(Outperforming Nifty)
Return vs Nifty
19.9%(Beating Nifty)
EMA 200
2212.1
EMA 50
2351.8
SMA 200
2211.3
vs SMA 50
-7.1%(Below SMA50)
vs SMA 200
-0.9%(Below SMA200)
Volume
8.16L
Avg Vol 3M
5.5L
Shareholding Pattern
Promoter
46.7%
Moderate
FII
20.3%
Strong foreign interest
DII / MF
19.3%
Strong MF interest
Share GLENMARK
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.